Concepedia

Dhana Sekhar Reddy Bandi

DS

Statistics

Publications

4

Citations

63

H-Index

4

Active since

2023

Affiliations

University of Alabama at Birmingham(Current)

Auburn University

University of Connecticut

Samford University

University of Illinois Chicago

Dhana Sekhar Reddy Bandi is an author at University of Alabama at Birmingham specializing in signal transduction in cancer, ras family oncogenes, and mapk signaling.

ORCID

Publications per year

2023–2025

4

Publications

4

A Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth and Induces Antitumor Immunity in Gastrointestinal Cancer

Jeremy B. Foote, Tyler Mattox, Adam B. Keeton et al. · Cancer Research · 2024 · 22 citations · Full text

, , +17

ADT-1004: a first-in-class, oral pan-RAS inhibitor with robust antitumor activity in preclinical models of pancreatic ductal adenocarcinoma

Dhana Sekhar Reddy Bandi, Ganji Purnachandra Nagaraju, Sujith Sarvesh et al. · Molecular Cancer · 2025 · 16 citations · Full text

, , +15

Mechanism of enhancing chemotherapy efficacy in pancreatic ductal adenocarcinoma with paricalcitol and hydroxychloroquine

Ganji Purnachandra Nagaraju, Madhu Sudhana Saddala, Jeremy B. Foote et al. · Cell Reports Medicine · 2024 · 13 citations · Full text

, , +17

A Novel Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth in Mouse Models of GI Cancer

Jeremy B. Foote, Tyler Mattox, Adam B. Keeton et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2023 · 12 citations · Full text

, , +17

1–4 of 4